Quince Therapeutics, Inc. (QNCX)

NASDAQ: QNCX · Real-Time Price · USD

0.9337

-0.0133 (-1.40%)

At close: Jun 12, 2026, 4:00 PM EDT

0.9005

-0.0332 (-3.56%)

After-hours: Jun 12, 2026, 7:37 PM EDT

Quince Therapeutics Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Quince Therapeutics in the last 12 months.

Price Target: n/a

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$0.00	$0.00	$0.00	$0.00
Change	n/a	n/a	n/a	n/a

Analyst Ratings

The average analyst rating for Quince Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	May '26
Strong Buy	4	4	4	1	0	0
Buy	2	2	2	0	0	0
Hold	0	0	0	4	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	1	1	0
Total	6	6	6	6	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Feb 2, 2026
Elemer Piros Lucid Capital	Lucid Capital	Sell Downgrades n/a	Sell	Downgrades	n/a	n/a	Jan 30, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jan 30, 2026
Jonathan Wolleben Citizens JMP	Citizens JMP	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jan 30, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

25.58M

EPS This Year

-15.30

from -16.80

EPS Next Year

-9.00

from -15.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-90.32M	-50.09M	-24.64M	-36.17M	-50.43M	-33.33M
Net Income	-89.95M	-51.66M	-31.39M	-56.83M	-83.98M	-33.33M
EPS	-	-	-	-	-16.80	-15.30
Free Cash Flow	-30.54M	-24.18M	-1.94M	-21.13M	-11.18M	-47.89M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-15.30
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-